Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Update

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 5,796 shares, a decrease of 62.7% from the August 15th total of 15,534 shares. Based on an average daily trading volume, of 14,071 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.5% of the company’s stock are short sold.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF in the third quarter valued at $11,239,000. WT Wealth Management raised its holdings in shares of Global X HealthTech ETF by 14.7% in the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after acquiring an additional 12,945 shares during the last quarter. Flow Traders U.S. LLC bought a new position in Global X HealthTech ETF in the 3rd quarter valued at about $368,000. Raymond James Financial Inc. bought a new position in Global X HealthTech ETF in the 3rd quarter valued at about $274,000. Finally, Citadel Advisors LLC acquired a new position in Global X HealthTech ETF during the 3rd quarter valued at about $216,000.

Global X HealthTech ETF Stock Up 0.7%

NASDAQ:HEAL traded up $0.18 on Friday, hitting $28.48. The stock had a trading volume of 2,756 shares, compared to its average volume of 10,499. The company has a market cap of $30.18 million, a PE ratio of 42.80 and a beta of 1.11. Global X HealthTech ETF has a 52 week low of $23.00 and a 52 week high of $33.59. The business’s fifty day moving average is $28.54 and its 200 day moving average is $26.51.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.